Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: A safe and effective therapy?
To access this article, please choose from the options below
PII: S0016-5085(04)01574-4
doi:10.1053/j.gastro.2004.09.005
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.

